secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2026-06-10T21:22:21+00:00
Accession:  0001193125-26-266078
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics raises ~$566.5M in public offering to fund R&D and commercialization
--------------------------------------------------------------------------------

- Offering of 18,166,667 shares at $30.00/share and pre-funded warrants for 1,833,395 shares at $29.999/warrant.
- Net proceeds expected ~$566.5M after underwriting discounts and expenses; closing expected June 11, 2026.
- Proceeds for R&D, pivotal trial, potential commercialization, G&A, and capex; cash runway extended into 2030.
- Underwriters granted 30-day option to purchase up to 3,000,009 additional shares at public offering price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312526266078/0001193125-26-266078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312526266078/d81492d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-266078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer